Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Simson Garfinkel

A View from Simson Garfinkel

Dr. Ecstasy

Today’s New York TImes Magazine has a big article about Dr. Alexander Shulgin, who invented more than 100 hallucinogens and was, in all likelihood, the first person to try Ecstasy (MDMA) in humans. Shulgin is a really good guy, he’s…

  • January 30, 2005

Today’s New York TImes Magazine has a big article about Dr. Alexander Shulgin, who invented more than 100 hallucinogens and was, in all likelihood, the first person to try Ecstasy (MDMA) in humans. Shulgin is a really good guy, he’s previously been a consultant for the DEA, and he’s got a wicked-cool lab in California that I’ve visited on multiple occasions. Even if you’re not interested by psychedelic drugs, you should read this article — because Ecstasy is increasingly being put into trials as a possible cure for PTSD and other psychological disorders.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    Print + Digital Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

    Technology Review PDF magazine archive, including articles, images, and covers dating back to 1899

    10% Discount to MIT Technology Review events and MIT Press

    Ad-free website experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.